I believe the author addressed that here:
"With more than double the industry leader's margins, Goldfield's margins are bound to come back down as the company encounters competitive forces in the industry which will cut EBITDA by roughly half assuming the company can find a similarly sized replacement project for the current CREZ project rolling off in 3Q13. Worse case, the company is unable to find a similarly sized project and is left levered up, having taken on debt to buy the equipment required to service the existing contract.
In the best case scenario: assuming peer leading margins (more than 50% less than today's) and a replacement contract for the current CREZ contract, GV shares are worth 50% of today's price or about $2.30 per share.
In the worst case scenario: a return to operations as they were prior to February 2012 (date of current CREZ contract award), GV shares should return to where they were at that time. The 5 day average close prior to the announcement of the contract was $0.32 per share."
I'll say if I was a long I wouldn't be comfortable with him calling it a "challenge" which seems a little extra cautionary. Also merely replacing the lost business isn't enough as the valuation already reflects that from this level.
"With more than double the industry leader's margins, Goldfield's margins are bound to come back down as the company encounters competitive forces in the industry which will cut EBITDA by roughly half assuming the company can find a similarly sized replacement project for the current CREZ project rolling off in 3Q13. Worse case, the company is unable to find a similarly sized project and is left levered up, having taken on debt to buy the equipment required to service the existing contract.
In the best case scenario: assuming peer leading margins (more than 50% less than today's) and a replacement contract for the current CREZ contract, GV shares are worth 50% of today's price or about $2.30 per share.
In the worst case scenario: a return to operations as they were prior to February 2012 (date of current CREZ contract award), GV shares should return to where they were at that time. The 5 day average close prior to the announcement of the contract was $0.32 per share."
I'll say if I was a long I wouldn't be comfortable with him calling it a "challenge" which seems a little extra cautionary. Also merely replacing the lost business isn't enough as the valuation already reflects that from this level.
Raw
Research & analysis on some of my favorite stocks is located on the sticky note on the SwingTrade board.
http://investorshub.advfn.com/boards/board.aspx?board_id=1781
Recent GV News
- Visionary Holdings receives Nasdaq notice over delayed financial filing • IH Market News • 04/07/2026 03:05:22 PM
- Visionary Holdings Inc. Announces Receipt of Nasdaq Continued Listing Deficiency Letter • GlobeNewswire Inc. • 04/07/2026 01:31:00 PM
- Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project • GlobeNewswire Inc. • 03/31/2026 02:01:24 PM
- Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China • GlobeNewswire Inc. • 03/26/2026 01:30:00 PM
- UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses • GlobeNewswire Inc. • 03/09/2026 12:30:00 PM
- Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales • GlobeNewswire Inc. • 03/05/2026 02:30:00 PM
- Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses • GlobeNewswire Inc. • 03/02/2026 02:30:00 PM
- Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract • GlobeNewswire Inc. • 02/24/2026 02:50:00 PM
- Visionary Holdings (Nasdaq: GV) Establishes Three Wholly Owned Subsidiaries in Qingdao, Wuxi and Wuhu, Advancing Commercial Expansion in China • GlobeNewswire Inc. • 02/18/2026 02:31:00 PM
- Visionary Holdings Inc. Secures $450,000 in Debt Financing • GlobeNewswire Inc. • 02/13/2026 09:30:00 PM
- Visionary Holdings Inc. Announces Resolution of Nasdaq Filing Deficiency and Confirmation of Continued Listing • GlobeNewswire Inc. • 02/04/2026 07:44:01 PM
- Visionary Holdings Inc. Regains Compliance with Nasdaq Periodic Filing Requirement • GlobeNewswire Inc. • 02/02/2026 02:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/28/2026 08:59:25 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/28/2026 08:09:49 PM
- CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending • GlobeNewswire Inc. • 01/21/2026 02:37:59 AM
- CORRECTION – Visionary Holdings Inc. • GlobeNewswire Inc. • 01/14/2026 03:36:40 AM
- Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report • GlobeNewswire Inc. • 01/13/2026 04:38:56 AM
- Visionary Holdings Inc. Announces Key Governance Updates, Strategic Pivot to High-End Medical Aesthetics, and Timeline for Annual Report Filing • GlobeNewswire Inc. • 12/30/2025 08:09:27 PM
- Visionary Holdings (Nasdaq: GV) Appoints CEO of Health Technology Business, Establishes New Sales Entity in Nanjing to Accelerate Commercial Execution in China Market • GlobeNewswire Inc. • 12/30/2025 02:30:00 PM
- Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market • PR Newswire (US) • 11/10/2025 02:30:00 PM
- Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development • PR Newswire (US) • 11/04/2025 02:30:00 PM
- Visionary Holdings Inc. 2025 Annual General Meeting Concludes Successfully: Completes Board Renewal, Anchors New Direction for Compliant Development • PR Newswire (US) • 10/31/2025 01:30:00 PM
- Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing • PR Newswire (US) • 10/25/2025 08:00:00 PM
- Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity • PR Newswire (US) • 10/22/2025 01:30:00 PM
- Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation • PR Newswire (US) • 10/17/2025 01:30:00 PM
